ID   MRP1_HUMAN              Reviewed;        1531 AA.
AC   P33527; A3RJX2; C9JPJ4; O14819; O43333; P78419; Q59GI9; Q9UQ97;
AC   Q9UQ99; Q9UQA0;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 3.
DT   10-MAY-2017, entry version 184.
DE   RecName: Full=Multidrug resistance-associated protein 1;
DE   AltName: Full=ATP-binding cassette sub-family C member 1;
DE   AltName: Full=Leukotriene C(4) transporter;
DE            Short=LTC4 transporter;
GN   Name=ABCC1; Synonyms=MRP, MRP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT THR-117.
RX   PubMed=1360704; DOI=10.1126/science.1360704;
RA   Cole S.P.C., Bhardwaj G., Gerlach J.H., Mackie J.E., Grant C.E.,
RA   Almquist K.C., Stewart A.J., Kurz E.U., Duncan A.M.V., Deeley R.G.;
RT   "Overexpression of a transporter gene in a multidrug-resistant human
RT   lung cancer cell line.";
RL   Science 258:1650-1654(1992).
RN   [2]
RP   SEQUENCE REVISION.
RX   PubMed=8098549; DOI=10.1126/science.8098549;
RA   Cole S.P.C., Deeley R.G.;
RT   "Multidrug resistance-associated protein: sequence correction.";
RL   Science 260:879-879(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], ALTERNATIVE SPLICING, AND VARIANT
RP   THR-117.
RX   PubMed=9344662; DOI=10.1006/geno.1997.4950;
RA   Grant C.E., Kurz E.U., Cole S.P.C., Deeley R.G.;
RT   "Analysis of the intron-exon organization of the human multidrug-
RT   resistance protein gene (MRP) and alternative splicing of its mRNA.";
RL   Genomics 45:368-378(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS VAL-671; GLN-723;
RP   THR-861; SER-1047 AND ILE-1146.
RG   NIEHS SNPs program;
RL   Submitted (FEB-2007) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 103-1531 (ISOFORM 9).
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] OF 516-1531.
RX   PubMed=10493829; DOI=10.1006/geno.1999.5927;
RA   Loftus B.J., Kim U.-J., Sneddon V.P., Kalush F., Brandon R.,
RA   Fuhrmann J., Mason T., Crosby M.L., Barnstead M., Cronin L.,
RA   Mays A.D., Cao Y., Xu R.X., Kang H.-L., Mitchell S., Eichler E.E.,
RA   Harris P.C., Venter J.C., Adams M.D.;
RT   "Genome duplications and other features in 12 Mb of DNA sequence from
RT   human chromosome 16p and 16q.";
RL   Genomics 60:295-308(1999).
RN   [8]
RP   TOPOLOGY, AND GLYCOSYLATION AT ASN-19; ASN-23 AND ASN-1006.
RX   PubMed=9295302; DOI=10.1074/jbc.272.38.23623;
RA   Hipfner D.R., Almquist K.C., Leslie E.M., Gerlach J.H., Grant C.E.,
RA   Deeley R.G., Cole S.P.C.;
RT   "Membrane topology of the multidrug resistance protein (MRP). A study
RT   of glycosylation-site mutants reveals an extracytosolic NH2
RT   terminus.";
RL   J. Biol. Chem. 272:23623-23630(1997).
RN   [9]
RP   TOPOLOGY.
RX   PubMed=9334225; DOI=10.1074/jbc.272.42.26479;
RA   Kast C., Gros P.;
RT   "Topology mapping of the amino-terminal half of multidrug resistance-
RT   associated protein by epitope insertion and immunofluorescence.";
RL   J. Biol. Chem. 272:26479-26487(1997).
RN   [10]
RP   TOPOLOGY.
RX   PubMed=9485377; DOI=10.1021/bi972332v;
RA   Kast C., Gros P.;
RT   "Epitope insertion favors a six transmembrane domain model for the
RT   carboxy-terminal portion of the multidrug resistance-associated
RT   protein.";
RL   Biochemistry 37:2305-2313(1998).
RN   [11]
RP   FUNCTION.
RX   PubMed=10064732;
RA   Sjoelinder M., Tornhamre S., Claesson H.-E., Hydman J., Lindgren J.A.;
RT   "Characterization of a leukotriene C4 export mechanism in human
RT   platelets: possible involvement of multidrug resistance-associated
RT   protein 1.";
RL   J. Lipid Res. 40:439-446(1999).
RN   [12]
RP   FUNCTION.
RX   PubMed=11114332; DOI=10.1016/S0092-8674(00)00179-3;
RA   Robbiani D.F., Finch R.A., Jaeger D., Muller W.A., Sartorelli A.C.,
RA   Randolph G.J.;
RT   "The leukotriene C(4) transporter MRP1 regulates CCL19 (MIP-3beta,
RT   ELC)-dependent mobilization of dendritic cells to lymph nodes.";
RL   Cell 103:757-768(2000).
RN   [13]
RP   MUTAGENESIS OF ASP-792; ASP-793; LYS-1333 AND 1454-ASP-GLU-1455.
RX   PubMed=11469806; DOI=10.1006/abbi.2001.2441;
RA   Cui L., Hou Y.-X., Riordan J.R., Chang X.-B.;
RT   "Mutations of the Walker B motif in the first nucleotide binding
RT   domain of multidrug resistance protein MRP1 prevent conformational
RT   maturation.";
RL   Arch. Biochem. Biophys. 392:153-161(2001).
RN   [14]
RP   MUTAGENESIS OF TRP-1246.
RX   PubMed=11278867; DOI=10.1074/jbc.M011246200;
RA   Ito K., Olsen S.L., Qiu W., Deeley R.G., Cole S.P.C.;
RT   "Mutation of a single conserved tryptophan in multidrug resistance
RT   protein 1 (MRP1/ABCC1) results in loss of drug resistance and
RT   selective loss of organic anion transport.";
RL   J. Biol. Chem. 276:15616-15624(2001).
RN   [15]
RP   MUTAGENESIS OF GLU-1089.
RX   PubMed=11278596; DOI=10.1074/jbc.M010008200;
RA   Zhang D.-W., Cole S.P.C., Deeley R.G.;
RT   "Identification of an amino acid residue in multidrug resistance
RT   protein 1 critical for conferring resistance to anthracyclines.";
RL   J. Biol. Chem. 276:13231-13239(2001).
RN   [16]
RP   MUTAGENESIS OF ARG-1046; ASP-1084 AND ARG-1131.
RX   PubMed=15208328; DOI=10.1074/jbc.M403832200;
RA   Situ D., Haimeur A., Conseil G., Sparks K.E., Zhang D.-W.,
RA   Deeley R.G., Cole S.P.C.;
RT   "Mutational analysis of ionizable residues proximal to the cytoplasmic
RT   interface of membrane spanning domain 3 of the multidrug resistance
RT   protein, MRP1 (ABCC1): glutamate 1204 is important for both the
RT   expression and catalytic activity of the transporter.";
RL   J. Biol. Chem. 279:38871-38880(2004).
RN   [17]
RP   MUTAGENESIS OF GLN-580; THR-581; SER-585; ASN-597; SER-604 AND
RP   SER-605.
RX   PubMed=15260484; DOI=10.1021/bi0495230;
RA   Zhang D.-W., Nunoya K., Vasa M., Gu H.-M., Theis A., Cole S.P.C.,
RA   Deeley R.G.;
RT   "Transmembrane helix 11 of multidrug resistance protein 1
RT   (MRP1/ABCC1): identification of polar amino acids important for
RT   substrate specificity and binding of ATP at nucleotide binding domain
RT   1.";
RL   Biochemistry 43:9413-9425(2004).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [19]
RP   FUNCTION, MUTAGENESIS OF ARG-1138; LYS-1141 AND ARG-1142, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=16230346; DOI=10.1074/jbc.M510143200;
RA   Conseil G., Deeley R.G., Cole S.P.;
RT   "Functional importance of three basic residues clustered at the
RT   cytosolic interface of transmembrane helix 15 in the multidrug and
RT   organic anion transporter MRP1 (ABCC1).";
RL   J. Biol. Chem. 281:43-50(2006).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-915, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-905 AND SER-930, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-930, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-915, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [27]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [28]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 642-871 IN COMPLEX WITH
RP   MG-ATP.
RX   PubMed=16697012; DOI=10.1016/j.jmb.2006.04.005;
RA   Ramaen O., Leulliot N., Sizun C., Ulryck N., Pamlard O.,
RA   Lallemand J.-Y., Tilbeurgh H., Jacquet E.;
RT   "Structure of the human multidrug resistance protein 1 nucleotide
RT   binding domain 1 bound to Mg2+/ATP reveals a non-productive catalytic
RT   site.";
RL   J. Mol. Biol. 359:940-949(2006).
RN   [29]
RP   VARIANTS GLN-633 AND VAL-671.
RX   PubMed=10835642; DOI=10.1038/76102;
RA   Le Saux O., Urban Z., Tschuch C., Csiszar K., Bacchelli B.,
RA   Quaglino D., Pasquali-Ronchetti I., Pope F.M., Richards A., Terry S.,
RA   Bercovitch L., de Paepe A., Boyd C.D.;
RT   "Mutations in a gene encoding an ABC transporter cause pseudoxanthoma
RT   elasticum.";
RL   Nat. Genet. 25:223-227(2000).
RN   [30]
RP   VARIANT VAL-671.
RX   PubMed=10811882; DOI=10.1073/pnas.100041297;
RA   Ringpfeil F., Lebwohl M.G., Christiano A.M., Uitto J.;
RT   "Pseudoxanthoma elasticum: mutations in the MRP6 gene encoding a
RT   transmembrane ATP-binding cassette (ABC) transporter.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:6001-6006(2000).
RN   [31]
RP   VARIANT SER-433, AND CHARACTERIZATION OF VARIANT VAL-671.
RX   PubMed=11721885; DOI=10.1007/s100380170017;
RA   Conrad S., Kauffmann H.-M., Ito K., Deeley R.G., Cole S.P.C.,
RA   Schrenk D.;
RT   "Identification of human multidrug resistance protein 1 (MRP1)
RT   mutations and characterization of a G671V substitution.";
RL   J. Hum. Genet. 46:656-663(2001).
RN   [32]
RP   VARIANTS THR-117 AND LEU-1512.
RX   PubMed=11139250;
RX   DOI=10.1002/1098-1004(2001)17:1<74::AID-HUMU14>3.0.CO;2-F;
RA   Perdu J., Germain D.P.;
RT   "Identification of novel polymorphisms in the pM5 and MRP1 (ABCC1)
RT   genes at locus 16p13.1 and exclusion of both genes as responsible for
RT   pseudoxanthoma elasticum.";
RL   Hum. Mutat. 17:74-75(2001).
RN   [33]
RP   VARIANTS SER-43; ILE-73; GLN-723 AND GLN-1058.
RX   PubMed=11266082; DOI=10.1097/00008571-200103000-00008;
RA   Ito S., Ieiri I., Tanabe M., Suzuki A., Higuchi S., Otsubo K.;
RT   "Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT,
RT   in healthy Japanese subjects.";
RL   Pharmacogenetics 11:175-184(2001).
RN   [34]
RP   VARIANT [LARGE SCALE ANALYSIS] SER-433.
RX   PubMed=18987736; DOI=10.1038/nature07485;
RA   Ley T.J., Mardis E.R., Ding L., Fulton B., McLellan M.D., Chen K.,
RA   Dooling D., Dunford-Shore B.H., McGrath S., Hickenbotham M., Cook L.,
RA   Abbott R., Larson D.E., Koboldt D.C., Pohl C., Smith S., Hawkins A.,
RA   Abbott S., Locke D., Hillier L.W., Miner T., Fulton L., Magrini V.,
RA   Wylie T., Glasscock J., Conyers J., Sander N., Shi X., Osborne J.R.,
RA   Minx P., Gordon D., Chinwalla A., Zhao Y., Ries R.E., Payton J.E.,
RA   Westervelt P., Tomasson M.H., Watson M., Baty J., Ivanovich J.,
RA   Heath S., Shannon W.D., Nagarajan R., Walter M.J., Link D.C.,
RA   Graubert T.A., DiPersio J.F., Wilson R.K.;
RT   "DNA sequencing of a cytogenetically normal acute myeloid leukaemia
RT   genome.";
RL   Nature 456:66-72(2008).
CC   -!- FUNCTION: Mediates export of organic anions and drugs from the
CC       cytoplasm. Mediates ATP-dependent transport of glutathione and
CC       glutathione conjugates, leukotriene C4, estradiol-17-beta-o-
CC       glucuronide, methotrexate, antiviral drugs and other xenobiotics.
CC       Confers resistance to anticancer drugs. Hydrolyzes ATP with low
CC       efficiency. {ECO:0000269|PubMed:10064732,
CC       ECO:0000269|PubMed:11114332, ECO:0000269|PubMed:16230346}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:16230346};
CC       Multi-pass membrane protein {ECO:0000255|PROSITE-ProRule:PRU00441,
CC       ECO:0000269|PubMed:16230346}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=9;
CC         Comment=Additional isoforms seem to exist. Experimental
CC         confirmation may be lacking for some isoforms.;
CC       Name=1; Synonyms=Allexons;
CC         IsoId=P33527-1; Sequence=Displayed;
CC       Name=2; Synonyms=Delexon-17;
CC         IsoId=P33527-2; Sequence=VSP_000037;
CC       Name=3; Synonyms=Delexon-18;
CC         IsoId=P33527-3; Sequence=VSP_000038;
CC       Name=4; Synonyms=Delexon-30;
CC         IsoId=P33527-4; Sequence=VSP_000039;
CC       Name=5; Synonyms=Delexon-17-18;
CC         IsoId=P33527-5; Sequence=VSP_000037, VSP_000038;
CC       Name=6; Synonyms=Delexon-17-30;
CC         IsoId=P33527-6; Sequence=VSP_000037, VSP_000039;
CC       Name=7; Synonyms=Delexon-18-30;
CC         IsoId=P33527-7; Sequence=VSP_000038, VSP_000039;
CC       Name=8; Synonyms=Delexon-17-18-30;
CC         IsoId=P33527-8; Sequence=VSP_000037, VSP_000038, VSP_000039;
CC       Name=9;
CC         IsoId=P33527-9; Sequence=VSP_017014;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Lung, testis and peripheral blood mononuclear
CC       cells.
CC   -!- SIMILARITY: Belongs to the ABC transporter superfamily. ABCC
CC       family. Conjugate transporter (TC 3.A.1.208) subfamily.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/MRPID106.html";
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/abcc1/";
CC   -!- WEB RESOURCE: Name=ABCMdb; Note=Database for mutations in ABC
CC       proteins;
CC       URL="http://abcmutations.hegelab.org/proteinDetails?uniprot_id=P33527";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L05628; AAB46616.1; -; mRNA.
DR   EMBL; AF022853; AAB83979.1; -; Genomic_DNA.
DR   EMBL; AF022827; AAB83979.1; JOINED; Genomic_DNA.
DR   EMBL; AF022828; AAB83979.1; JOINED; Genomic_DNA.
DR   EMBL; AF022829; AAB83979.1; JOINED; Genomic_DNA.
DR   EMBL; AF022831; AAB83979.1; JOINED; Genomic_DNA.
DR   EMBL; AF022833; AAB83979.1; JOINED; Genomic_DNA.
DR   EMBL; AF022835; AAB83979.1; JOINED; Genomic_DNA.
DR   EMBL; AF022837; AAB83979.1; JOINED; Genomic_DNA.
DR   EMBL; AF022839; AAB83979.1; JOINED; Genomic_DNA.
DR   EMBL; AF022841; AAB83979.1; JOINED; Genomic_DNA.
DR   EMBL; AF022850; AAB83979.1; JOINED; Genomic_DNA.
DR   EMBL; AF022849; AAB83979.1; JOINED; Genomic_DNA.
DR   EMBL; AF022848; AAB83979.1; JOINED; Genomic_DNA.
DR   EMBL; AF022847; AAB83979.1; JOINED; Genomic_DNA.
DR   EMBL; AF022846; AAB83979.1; JOINED; Genomic_DNA.
DR   EMBL; AF022845; AAB83979.1; JOINED; Genomic_DNA.
DR   EMBL; AF022844; AAB83979.1; JOINED; Genomic_DNA.
DR   EMBL; AF022843; AAB83979.1; JOINED; Genomic_DNA.
DR   EMBL; AF022842; AAB83979.1; JOINED; Genomic_DNA.
DR   EMBL; AF022852; AAB83979.1; JOINED; Genomic_DNA.
DR   EMBL; AF022851; AAB83979.1; JOINED; Genomic_DNA.
DR   EMBL; AF022840; AAB83979.1; JOINED; Genomic_DNA.
DR   EMBL; AF022838; AAB83979.1; JOINED; Genomic_DNA.
DR   EMBL; AF022836; AAB83979.1; JOINED; Genomic_DNA.
DR   EMBL; AF022834; AAB83979.1; JOINED; Genomic_DNA.
DR   EMBL; AF022832; AAB83979.1; JOINED; Genomic_DNA.
DR   EMBL; AF022826; AAB83979.1; JOINED; Genomic_DNA.
DR   EMBL; AF022825; AAB83979.1; JOINED; Genomic_DNA.
DR   EMBL; AF022824; AAB83979.1; JOINED; Genomic_DNA.
DR   EMBL; AF022830; AAB83979.1; JOINED; Genomic_DNA.
DR   EMBL; AF022853; AAB83980.1; -; Genomic_DNA.
DR   EMBL; AF022824; AAB83980.1; JOINED; Genomic_DNA.
DR   EMBL; AF022825; AAB83980.1; JOINED; Genomic_DNA.
DR   EMBL; AF022826; AAB83980.1; JOINED; Genomic_DNA.
DR   EMBL; AF022828; AAB83980.1; JOINED; Genomic_DNA.
DR   EMBL; AF022830; AAB83980.1; JOINED; Genomic_DNA.
DR   EMBL; AF022832; AAB83980.1; JOINED; Genomic_DNA.
DR   EMBL; AF022834; AAB83980.1; JOINED; Genomic_DNA.
DR   EMBL; AF022836; AAB83980.1; JOINED; Genomic_DNA.
DR   EMBL; AF022838; AAB83980.1; JOINED; Genomic_DNA.
DR   EMBL; AF022848; AAB83980.1; JOINED; Genomic_DNA.
DR   EMBL; AF022847; AAB83980.1; JOINED; Genomic_DNA.
DR   EMBL; AF022846; AAB83980.1; JOINED; Genomic_DNA.
DR   EMBL; AF022845; AAB83980.1; JOINED; Genomic_DNA.
DR   EMBL; AF022844; AAB83980.1; JOINED; Genomic_DNA.
DR   EMBL; AF022843; AAB83980.1; JOINED; Genomic_DNA.
DR   EMBL; AF022842; AAB83980.1; JOINED; Genomic_DNA.
DR   EMBL; AF022841; AAB83980.1; JOINED; Genomic_DNA.
DR   EMBL; AF022839; AAB83980.1; JOINED; Genomic_DNA.
DR   EMBL; AF022852; AAB83980.1; JOINED; Genomic_DNA.
DR   EMBL; AF022851; AAB83980.1; JOINED; Genomic_DNA.
DR   EMBL; AF022850; AAB83980.1; JOINED; Genomic_DNA.
DR   EMBL; AF022849; AAB83980.1; JOINED; Genomic_DNA.
DR   EMBL; AF022837; AAB83980.1; JOINED; Genomic_DNA.
DR   EMBL; AF022835; AAB83980.1; JOINED; Genomic_DNA.
DR   EMBL; AF022833; AAB83980.1; JOINED; Genomic_DNA.
DR   EMBL; AF022831; AAB83980.1; JOINED; Genomic_DNA.
DR   EMBL; AF022829; AAB83980.1; JOINED; Genomic_DNA.
DR   EMBL; AF022827; AAB83980.1; JOINED; Genomic_DNA.
DR   EMBL; AF022853; AAB83981.1; -; Genomic_DNA.
DR   EMBL; AF022824; AAB83981.1; JOINED; Genomic_DNA.
DR   EMBL; AF022825; AAB83981.1; JOINED; Genomic_DNA.
DR   EMBL; AF022826; AAB83981.1; JOINED; Genomic_DNA.
DR   EMBL; AF022827; AAB83981.1; JOINED; Genomic_DNA.
DR   EMBL; AF022829; AAB83981.1; JOINED; Genomic_DNA.
DR   EMBL; AF022831; AAB83981.1; JOINED; Genomic_DNA.
DR   EMBL; AF022833; AAB83981.1; JOINED; Genomic_DNA.
DR   EMBL; AF022835; AAB83981.1; JOINED; Genomic_DNA.
DR   EMBL; AF022837; AAB83981.1; JOINED; Genomic_DNA.
DR   EMBL; AF022847; AAB83981.1; JOINED; Genomic_DNA.
DR   EMBL; AF022846; AAB83981.1; JOINED; Genomic_DNA.
DR   EMBL; AF022845; AAB83981.1; JOINED; Genomic_DNA.
DR   EMBL; AF022844; AAB83981.1; JOINED; Genomic_DNA.
DR   EMBL; AF022843; AAB83981.1; JOINED; Genomic_DNA.
DR   EMBL; AF022842; AAB83981.1; JOINED; Genomic_DNA.
DR   EMBL; AF022841; AAB83981.1; JOINED; Genomic_DNA.
DR   EMBL; AF022840; AAB83981.1; JOINED; Genomic_DNA.
DR   EMBL; AF022838; AAB83981.1; JOINED; Genomic_DNA.
DR   EMBL; AF022852; AAB83981.1; JOINED; Genomic_DNA.
DR   EMBL; AF022851; AAB83981.1; JOINED; Genomic_DNA.
DR   EMBL; AF022850; AAB83981.1; JOINED; Genomic_DNA.
DR   EMBL; AF022849; AAB83981.1; JOINED; Genomic_DNA.
DR   EMBL; AF022848; AAB83981.1; JOINED; Genomic_DNA.
DR   EMBL; AF022836; AAB83981.1; JOINED; Genomic_DNA.
DR   EMBL; AF022834; AAB83981.1; JOINED; Genomic_DNA.
DR   EMBL; AF022832; AAB83981.1; JOINED; Genomic_DNA.
DR   EMBL; AF022830; AAB83981.1; JOINED; Genomic_DNA.
DR   EMBL; AF022828; AAB83981.1; JOINED; Genomic_DNA.
DR   EMBL; AF022853; AAB83983.1; -; Genomic_DNA.
DR   EMBL; AF022824; AAB83983.1; JOINED; Genomic_DNA.
DR   EMBL; AF022825; AAB83983.1; JOINED; Genomic_DNA.
DR   EMBL; AF022826; AAB83983.1; JOINED; Genomic_DNA.
DR   EMBL; AF022827; AAB83983.1; JOINED; Genomic_DNA.
DR   EMBL; AF022828; AAB83983.1; JOINED; Genomic_DNA.
DR   EMBL; AF022829; AAB83983.1; JOINED; Genomic_DNA.
DR   EMBL; AF022830; AAB83983.1; JOINED; Genomic_DNA.
DR   EMBL; AF022831; AAB83983.1; JOINED; Genomic_DNA.
DR   EMBL; AF022832; AAB83983.1; JOINED; Genomic_DNA.
DR   EMBL; AF022833; AAB83983.1; JOINED; Genomic_DNA.
DR   EMBL; AF022834; AAB83983.1; JOINED; Genomic_DNA.
DR   EMBL; AF022835; AAB83983.1; JOINED; Genomic_DNA.
DR   EMBL; AF022836; AAB83983.1; JOINED; Genomic_DNA.
DR   EMBL; AF022837; AAB83983.1; JOINED; Genomic_DNA.
DR   EMBL; AF022838; AAB83983.1; JOINED; Genomic_DNA.
DR   EMBL; AF022839; AAB83983.1; JOINED; Genomic_DNA.
DR   EMBL; AF022840; AAB83983.1; JOINED; Genomic_DNA.
DR   EMBL; AF022841; AAB83983.1; JOINED; Genomic_DNA.
DR   EMBL; AF022842; AAB83983.1; JOINED; Genomic_DNA.
DR   EMBL; AF022843; AAB83983.1; JOINED; Genomic_DNA.
DR   EMBL; AF022844; AAB83983.1; JOINED; Genomic_DNA.
DR   EMBL; AF022845; AAB83983.1; JOINED; Genomic_DNA.
DR   EMBL; AF022846; AAB83983.1; JOINED; Genomic_DNA.
DR   EMBL; AF022847; AAB83983.1; JOINED; Genomic_DNA.
DR   EMBL; AF022848; AAB83983.1; JOINED; Genomic_DNA.
DR   EMBL; AF022849; AAB83983.1; JOINED; Genomic_DNA.
DR   EMBL; AF022850; AAB83983.1; JOINED; Genomic_DNA.
DR   EMBL; AF022851; AAB83983.1; JOINED; Genomic_DNA.
DR   EMBL; EF419769; ABN79590.1; -; Genomic_DNA.
DR   EMBL; AC025778; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC130651; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC136624; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AB209120; BAD92357.1; -; mRNA.
DR   EMBL; U91318; AAC15784.1; -; Genomic_DNA.
DR   EMBL; AC003026; AAC05808.1; -; Genomic_DNA.
DR   CCDS; CCDS42122.1; -. [P33527-1]
DR   PIR; A44231; DVHUAR.
DR   RefSeq; NP_004987.2; NM_004996.3. [P33527-1]
DR   UniGene; Hs.391464; -.
DR   PDB; 2CBZ; X-ray; 1.50 A; A=642-871.
DR   PDB; 4C3Z; X-ray; 2.10 A; A=628-881.
DR   PDBsum; 2CBZ; -.
DR   PDBsum; 4C3Z; -.
DR   ProteinModelPortal; P33527; -.
DR   SMR; P33527; -.
DR   BioGrid; 110503; 54.
DR   IntAct; P33527; 14.
DR   MINT; MINT-2802626; -.
DR   STRING; 9606.ENSP00000382342; -.
DR   BindingDB; P33527; -.
DR   ChEMBL; CHEMBL3004; -.
DR   DrugBank; DB05812; Abiraterone.
DR   DrugBank; DB00345; Aminohippuric acid.
DR   DrugBank; DB00701; Amprenavir.
DR   DrugBank; DB01072; Atazanavir.
DR   DrugBank; DB01076; Atorvastatin.
DR   DrugBank; DB04851; Biricodar dicitrate.
DR   DrugBank; DB02659; Cholic Acid.
DR   DrugBank; DB01394; Colchicine.
DR   DrugBank; DB00286; Conjugated Equine Estrogens.
DR   DrugBank; DB00091; Cyclosporine.
DR   DrugBank; DB00970; Dactinomycin.
DR   DrugBank; DB00694; Daunorubicin.
DR   DrugBank; DB00586; Diclofenac.
DR   DrugBank; DB01248; Docetaxel.
DR   DrugBank; DB00997; Doxorubicin.
DR   DrugBank; DB00445; Epirubicin.
DR   DrugBank; DB00773; Etoposide.
DR   DrugBank; DB00693; Fluorescein.
DR   DrugBank; DB01645; Genistein.
DR   DrugBank; DB00143; Glutathione.
DR   DrugBank; DB01016; Glyburide.
DR   DrugBank; DB00365; Grepafloxacin.
DR   DrugBank; DB01050; Ibuprofen.
DR   DrugBank; DB01177; Idarubicin.
DR   DrugBank; DB00224; Indinavir.
DR   DrugBank; DB00328; Indomethacin.
DR   DrugBank; DB00762; Irinotecan.
DR   DrugBank; DB00602; Ivermectin.
DR   DrugBank; DB00709; Lamivudine.
DR   DrugBank; DB00563; Methotrexate.
DR   DrugBank; DB00834; Mifepristone.
DR   DrugBank; DB01204; Mitoxantrone.
DR   DrugBank; DB02375; Myricetin.
DR   DrugBank; DB03467; Naringenin.
DR   DrugBank; DB01165; Ofloxacin.
DR   DrugBank; DB01229; Paclitaxel.
DR   DrugBank; DB01174; Phenobarbital.
DR   DrugBank; DB01032; Probenecid.
DR   DrugBank; DB00396; Progesterone.
DR   DrugBank; DB04216; Quercetin.
DR   DrugBank; DB03825; Rhodamine 6G.
DR   DrugBank; DB01045; Rifampicin.
DR   DrugBank; DB00503; Ritonavir.
DR   DrugBank; DB01098; Rosuvastatin.
DR   DrugBank; DB01232; Saquinavir.
DR   DrugBank; DB06335; Saxagliptin.
DR   DrugBank; DB01138; Sulfinpyrazone.
DR   DrugBank; DB04348; Taurocholic Acid.
DR   DrugBank; DB09161; Technetium Tc-99m sestamibi.
DR   DrugBank; DB05294; Vandetanib.
DR   DrugBank; DB08881; Vemurafenib.
DR   DrugBank; DB00661; Verapamil.
DR   DrugBank; DB00570; Vinblastine.
DR   DrugBank; DB00541; Vincristine.
DR   DrugBank; DB00399; Zoledronic acid.
DR   GuidetoPHARMACOLOGY; 779; -.
DR   SwissLipids; SLP:000000404; -.
DR   TCDB; 3.A.1.208.8; the atp-binding cassette (abc) superfamily.
DR   iPTMnet; P33527; -.
DR   PhosphoSitePlus; P33527; -.
DR   SwissPalm; P33527; -.
DR   BioMuta; ABCC1; -.
DR   DMDM; 296439301; -.
DR   EPD; P33527; -.
DR   MaxQB; P33527; -.
DR   PaxDb; P33527; -.
DR   PeptideAtlas; P33527; -.
DR   PRIDE; P33527; -.
DR   Ensembl; ENST00000399410; ENSP00000382342; ENSG00000103222. [P33527-1]
DR   Ensembl; ENST00000621144; ENSP00000483316; ENSG00000278183. [P33527-1]
DR   GeneID; 4363; -.
DR   KEGG; hsa:4363; -.
DR   UCSC; uc010bvi.4; human. [P33527-1]
DR   CTD; 4363; -.
DR   DisGeNET; 4363; -.
DR   GeneCards; ABCC1; -.
DR   H-InvDB; HIX0134370; -.
DR   HGNC; HGNC:51; ABCC1.
DR   HPA; HPA002380; -.
DR   MIM; 158343; gene.
DR   neXtProt; NX_P33527; -.
DR   OpenTargets; ENSG00000103222; -.
DR   PharmGKB; PA244; -.
DR   eggNOG; KOG0054; Eukaryota.
DR   eggNOG; COG1132; LUCA.
DR   GeneTree; ENSGT00870000136442; -.
DR   HOVERGEN; HBG108314; -.
DR   InParanoid; P33527; -.
DR   KO; K05665; -.
DR   OMA; MFSGPQI; -.
DR   OrthoDB; EOG091G00IN; -.
DR   PhylomeDB; P33527; -.
DR   TreeFam; TF105199; -.
DR   Reactome; R-HSA-196741; Cobalamin (Cbl, vitamin B12) transport and metabolism.
DR   Reactome; R-HSA-2142691; Synthesis of Leukotrienes (LT) and Eoxins (EX).
DR   Reactome; R-HSA-382556; ABC-family proteins mediated transport.
DR   SIGNOR; P33527; -.
DR   ChiTaRS; ABCC1; human.
DR   EvolutionaryTrace; P33527; -.
DR   GeneWiki; ABCC1; -.
DR   GenomeRNAi; 4363; -.
DR   PRO; PR:P33527; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000103222; -.
DR   CleanEx; HS_ABCC1; -.
DR   ExpressionAtlas; P33527; baseline and differential.
DR   Genevisible; P33527; HS.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:CACAO.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; TAS:ProtInc.
DR   GO; GO:0016887; F:ATPase activity; IDA:UniProtKB.
DR   GO; GO:0042626; F:ATPase activity, coupled to transmembrane movement of substances; TAS:Reactome.
DR   GO; GO:0043225; F:ATPase-coupled anion transmembrane transporter activity; TAS:Reactome.
DR   GO; GO:0015420; F:cobalamin-transporting ATPase activity; TAS:Reactome.
DR   GO; GO:0015431; F:glutathione S-conjugate-exporting ATPase activity; IBA:GO_Central.
DR   GO; GO:0034634; F:glutathione transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:0005215; F:transporter activity; TAS:ProtInc.
DR   GO; GO:0008559; F:xenobiotic-transporting ATPase activity; IBA:GO_Central.
DR   GO; GO:0009235; P:cobalamin metabolic process; TAS:Reactome.
DR   GO; GO:0006855; P:drug transmembrane transport; IBA:GO_Central.
DR   GO; GO:0034775; P:glutathione transmembrane transport; IBA:GO_Central.
DR   GO; GO:0006691; P:leukotriene metabolic process; TAS:Reactome.
DR   GO; GO:0042493; P:response to drug; TAS:ProtInc.
DR   GO; GO:0055085; P:transmembrane transport; TAS:Reactome.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   GO; GO:0042908; P:xenobiotic transport; IBA:GO_Central.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR011527; ABC1_TM_dom.
DR   InterPro; IPR003439; ABC_transporter-like.
DR   InterPro; IPR017871; ABC_transporter_CS.
DR   InterPro; IPR030241; ABCC1.
DR   InterPro; IPR005292; Multidrug-R_assoc.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR24223:SF261; PTHR24223:SF261; 1.
DR   Pfam; PF00664; ABC_membrane; 2.
DR   Pfam; PF00005; ABC_tran; 2.
DR   SMART; SM00382; AAA; 2.
DR   SUPFAM; SSF52540; SSF52540; 2.
DR   SUPFAM; SSF90123; SSF90123; 2.
DR   TIGRFAMs; TIGR00957; MRP_assoc_pro; 1.
DR   PROSITE; PS50929; ABC_TM1F; 2.
DR   PROSITE; PS00211; ABC_TRANSPORTER_1; 2.
DR   PROSITE; PS50893; ABC_TRANSPORTER_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cell membrane;
KW   Complete proteome; Glycoprotein; Hydrolase; Membrane;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Reference proteome;
KW   Repeat; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1   1531       Multidrug resistance-associated protein
FT                                1.
FT                                /FTId=PRO_0000093351.
FT   TOPO_DOM      1     33       Extracellular.
FT   TRANSMEM     34     54       Helical; Name=1.
FT   TOPO_DOM     55     74       Cytoplasmic.
FT   TRANSMEM     75     95       Helical; Name=2.
FT   TOPO_DOM     96    100       Extracellular.
FT   TRANSMEM    101    121       Helical; Name=3.
FT   TOPO_DOM    122    133       Cytoplasmic.
FT   TRANSMEM    134    154       Helical; Name=4.
FT   TOPO_DOM    155    172       Extracellular.
FT   TRANSMEM    173    193       Helical; Name=5.
FT   TOPO_DOM    194    316       Cytoplasmic.
FT   TRANSMEM    317    337       Helical; Name=6.
FT   TOPO_DOM    338    363       Extracellular.
FT   TRANSMEM    364    384       Helical; Name=7.
FT   TOPO_DOM    385    440       Cytoplasmic.
FT   TRANSMEM    441    461       Helical; Name=8.
FT   TOPO_DOM    462    464       Extracellular.
FT   TRANSMEM    465    485       Helical; Name=9.
FT   TOPO_DOM    486    547       Cytoplasmic.
FT   TRANSMEM    548    568       Helical; Name=10.
FT   TOPO_DOM    569    590       Extracellular.
FT   TRANSMEM    591    611       Helical; Name=11.
FT   TOPO_DOM    612    967       Cytoplasmic.
FT   TRANSMEM    968    988       Helical; Name=12.
FT   TOPO_DOM    989   1025       Extracellular.
FT   TRANSMEM   1026   1046       Helical; Name=13.
FT   TOPO_DOM   1047   1089       Cytoplasmic.
FT   TRANSMEM   1090   1110       Helical; Name=14.
FT   TOPO_DOM   1111   1111       Extracellular.
FT   TRANSMEM   1112   1132       Helical; Name=15.
FT   TOPO_DOM   1133   1203       Cytoplasmic.
FT   TRANSMEM   1204   1224       Helical; Name=16.
FT   TOPO_DOM   1225   1226       Extracellular.
FT   TRANSMEM   1227   1247       Helical; Name=17.
FT   TOPO_DOM   1248   1531       Cytoplasmic.
FT   DOMAIN      325    608       ABC transmembrane type-1 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00441}.
FT   DOMAIN      644    868       ABC transporter 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00434}.
FT   DOMAIN      975   1256       ABC transmembrane type-1 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00441}.
FT   DOMAIN     1293   1527       ABC transporter 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00434}.
FT   NP_BIND     678    685       ATP 1.
FT   NP_BIND    1327   1334       ATP 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00434}.
FT   BINDING     653    653       ATP 1.
FT   BINDING     713    713       ATP 1.
FT   MOD_RES     277    277       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:O35379}.
FT   MOD_RES     289    289       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O35379}.
FT   MOD_RES     503    503       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:O35379}.
FT   MOD_RES     905    905       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     915    915       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     930    930       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692}.
FT   CARBOHYD     19     19       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:9295302}.
FT   CARBOHYD     23     23       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:9295302}.
FT   CARBOHYD   1006   1006       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:9295302}.
FT   VAR_SEQ     706    764       Missing (in isoform 2, isoform 5, isoform
FT                                6 and isoform 8). {ECO:0000305}.
FT                                /FTId=VSP_000037.
FT   VAR_SEQ     765    820       Missing (in isoform 3, isoform 5, isoform
FT                                7 and isoform 8). {ECO:0000305}.
FT                                /FTId=VSP_000038.
FT   VAR_SEQ     882    882       G -> GSTVMDEEEAG (in isoform 9).
FT                                {ECO:0000303|Ref.6}.
FT                                /FTId=VSP_017014.
FT   VAR_SEQ    1431   1495       Missing (in isoform 4, isoform 6, isoform
FT                                7 and isoform 8). {ECO:0000305}.
FT                                /FTId=VSP_000039.
FT   VARIANT      43     43       C -> S (in dbSNP:rs41395947).
FT                                {ECO:0000269|PubMed:11266082}.
FT                                /FTId=VAR_013317.
FT   VARIANT      73     73       T -> I (in dbSNP:rs41494447).
FT                                {ECO:0000269|PubMed:11266082}.
FT                                /FTId=VAR_013318.
FT   VARIANT     117    117       M -> T. {ECO:0000269|PubMed:11139250,
FT                                ECO:0000269|PubMed:1360704,
FT                                ECO:0000269|PubMed:9344662}.
FT                                /FTId=VAR_013319.
FT   VARIANT     433    433       R -> S (in dbSNP:rs60782127).
FT                                {ECO:0000269|PubMed:11721885,
FT                                ECO:0000269|PubMed:18987736}.
FT                                /FTId=VAR_013320.
FT   VARIANT     633    633       R -> Q (in dbSNP:rs112282109).
FT                                {ECO:0000269|PubMed:10835642}.
FT                                /FTId=VAR_011488.
FT   VARIANT     671    671       G -> V (no effect on leukotriene C4 and
FT                                estradiol glucuronide transport;
FT                                dbSNP:rs45511401).
FT                                {ECO:0000269|PubMed:10811882,
FT                                ECO:0000269|PubMed:10835642,
FT                                ECO:0000269|PubMed:11721885,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_011489.
FT   VARIANT     723    723       R -> Q (in dbSNP:rs4148356).
FT                                {ECO:0000269|PubMed:11266082,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_013321.
FT   VARIANT     861    861       A -> T (in dbSNP:rs45517537).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_055384.
FT   VARIANT    1047   1047       C -> S (in dbSNP:rs13337489).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_055385.
FT   VARIANT    1058   1058       R -> Q (in dbSNP:rs41410450).
FT                                {ECO:0000269|PubMed:11266082}.
FT                                /FTId=VAR_013322.
FT   VARIANT    1146   1146       V -> I (in dbSNP:rs28706727).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_055386.
FT   VARIANT    1512   1512       S -> L (in dbSNP:rs369410659).
FT                                {ECO:0000269|PubMed:11139250}.
FT                                /FTId=VAR_013323.
FT   MUTAGEN     580    580       Q->A: No effect.
FT                                {ECO:0000269|PubMed:15260484}.
FT   MUTAGEN     581    581       T->A: No effect.
FT                                {ECO:0000269|PubMed:15260484}.
FT   MUTAGEN     585    585       S->A: No effect.
FT                                {ECO:0000269|PubMed:15260484}.
FT   MUTAGEN     597    597       N->A: Increases resistance to vincristine
FT                                and decreases resistance to VP-16.
FT                                {ECO:0000269|PubMed:15260484}.
FT   MUTAGEN     604    604       S->A: Increases estradiol glucuronide
FT                                transport. {ECO:0000269|PubMed:15260484}.
FT   MUTAGEN     605    605       S->A: Decreases resistance to
FT                                vincristine, VP-16 and doxorubicin.
FT                                {ECO:0000269|PubMed:15260484}.
FT   MUTAGEN     792    792       D->A: Only partially affects protein
FT                                maturation; impairs leukotriene C4
FT                                transport. {ECO:0000269|PubMed:11469806}.
FT   MUTAGEN     792    792       D->L: Impairs protein maturation and
FT                                leukotriene C4 transport.
FT                                {ECO:0000269|PubMed:11469806}.
FT   MUTAGEN     793    793       D->L: No effect on protein maturation and
FT                                leukotriene C4 transport.
FT                                {ECO:0000269|PubMed:11469806}.
FT   MUTAGEN    1046   1046       R->D: Slightly impairs leukotriene C4 and
FT                                estradiol glucuronide transport.
FT                                {ECO:0000269|PubMed:15208328}.
FT   MUTAGEN    1084   1084       D->R: Impairs leukotriene C4 and
FT                                estradiol glucuronide transport.
FT                                {ECO:0000269|PubMed:15208328}.
FT   MUTAGEN    1089   1089       E->A,L,N,Q: Decreases resistance to
FT                                anthracyclines.
FT                                {ECO:0000269|PubMed:11278596}.
FT   MUTAGEN    1089   1089       E->D: No effect.
FT                                {ECO:0000269|PubMed:11278596}.
FT   MUTAGEN    1089   1089       E->K: Abolishes resistance to
FT                                anthracyclines.
FT                                {ECO:0000269|PubMed:11278596}.
FT   MUTAGEN    1131   1131       R->E: Slightly impairs leukotriene C4 and
FT                                estradiol glucuronide transport.
FT                                {ECO:0000269|PubMed:15208328}.
FT   MUTAGEN    1138   1138       R->E,K: Strongly reduced transport of
FT                                leukotriene C4, estradiol glucuronide and
FT                                of glutathione.
FT                                {ECO:0000269|PubMed:16230346}.
FT   MUTAGEN    1141   1141       K->E: Reduced transport of leukotriene C4
FT                                and of glutathione.
FT                                {ECO:0000269|PubMed:16230346}.
FT   MUTAGEN    1141   1141       K->R: Reduced transport of glutathione.
FT                                {ECO:0000269|PubMed:16230346}.
FT   MUTAGEN    1142   1142       R->E,K: Reduced transport of leukotriene
FT                                C4, estradiol glucuronide and of
FT                                glutathione.
FT                                {ECO:0000269|PubMed:16230346}.
FT   MUTAGEN    1246   1246       W->A,F,Y: Impairs estradiol glucuronide
FT                                transport. {ECO:0000269|PubMed:11278867}.
FT   MUTAGEN    1246   1246       W->C: Impairs estradiol glucuronide
FT                                transport; loss of resistance to alkaloid
FT                                vincristine, cationic anthracyclines,
FT                                epipodophyllotoxin VP-16, but not
FT                                potassium antimony tartrate; partial loss
FT                                of resistance to sodium arsenite.
FT                                {ECO:0000269|PubMed:11278867}.
FT   MUTAGEN    1333   1333       K->L: Impairs leukotriene C4 transport.
FT                                {ECO:0000269|PubMed:11469806}.
FT   MUTAGEN    1454   1455       DE->LL: Impairs leukotriene C4 transport.
FT                                {ECO:0000269|PubMed:11469806}.
FT   STRAND      644    653       {ECO:0000244|PDB:2CBZ}.
FT   STRAND      660    668       {ECO:0000244|PDB:2CBZ}.
FT   STRAND      673    677       {ECO:0000244|PDB:2CBZ}.
FT   HELIX       684    691       {ECO:0000244|PDB:2CBZ}.
FT   STRAND      695    704       {ECO:0000244|PDB:2CBZ}.
FT   STRAND      708    711       {ECO:0000244|PDB:2CBZ}.
FT   STRAND      719    721       {ECO:0000244|PDB:2CBZ}.
FT   HELIX       722    727       {ECO:0000244|PDB:2CBZ}.
FT   HELIX       736    743       {ECO:0000244|PDB:2CBZ}.
FT   HELIX       747    750       {ECO:0000244|PDB:2CBZ}.
FT   HELIX       756    758       {ECO:0000244|PDB:2CBZ}.
FT   STRAND      759    762       {ECO:0000244|PDB:2CBZ}.
FT   HELIX       770    784       {ECO:0000244|PDB:2CBZ}.
FT   STRAND      787    793       {ECO:0000244|PDB:2CBZ}.
FT   TURN        794    797       {ECO:0000244|PDB:2CBZ}.
FT   HELIX       800    809       {ECO:0000244|PDB:2CBZ}.
FT   TURN        816    819       {ECO:0000244|PDB:2CBZ}.
FT   STRAND      820    825       {ECO:0000244|PDB:2CBZ}.
FT   HELIX       832    834       {ECO:0000244|PDB:2CBZ}.
FT   STRAND      835    842       {ECO:0000244|PDB:2CBZ}.
FT   STRAND      845    850       {ECO:0000244|PDB:2CBZ}.
FT   HELIX       852    858       {ECO:0000244|PDB:2CBZ}.
FT   HELIX       861    868       {ECO:0000244|PDB:2CBZ}.
SQ   SEQUENCE   1531 AA;  171591 MW;  46A7CB643B9478C4 CRC64;
     MALRGFCSAD GSDPLWDWNV TWNTSNPDFT KCFQNTVLVW VPCFYLWACF PFYFLYLSRH
     DRGYIQMTPL NKTKTALGFL LWIVCWADLF YSFWERSRGI FLAPVFLVSP TLLGITMLLA
     TFLIQLERRK GVQSSGIMLT FWLVALVCAL AILRSKIMTA LKEDAQVDLF RDITFYVYFS
     LLLIQLVLSC FSDRSPLFSE TIHDPNPCPE SSASFLSRIT FWWITGLIVR GYRQPLEGSD
     LWSLNKEDTS EQVVPVLVKN WKKECAKTRK QPVKVVYSSK DPAQPKESSK VDANEEVEAL
     IVKSPQKEWN PSLFKVLYKT FGPYFLMSFF FKAIHDLMMF SGPQILKLLI KFVNDTKAPD
     WQGYFYTVLL FVTACLQTLV LHQYFHICFV SGMRIKTAVI GAVYRKALVI TNSARKSSTV
     GEIVNLMSVD AQRFMDLATY INMIWSAPLQ VILALYLLWL NLGPSVLAGV AVMVLMVPVN
     AVMAMKTKTY QVAHMKSKDN RIKLMNEILN GIKVLKLYAW ELAFKDKVLA IRQEELKVLK
     KSAYLSAVGT FTWVCTPFLV ALCTFAVYVT IDENNILDAQ TAFVSLALFN ILRFPLNILP
     MVISSIVQAS VSLKRLRIFL SHEELEPDSI ERRPVKDGGG TNSITVRNAT FTWARSDPPT
     LNGITFSIPE GALVAVVGQV GCGKSSLLSA LLAEMDKVEG HVAIKGSVAY VPQQAWIQND
     SLRENILFGC QLEEPYYRSV IQACALLPDL EILPSGDRTE IGEKGVNLSG GQKQRVSLAR
     AVYSNADIYL FDDPLSAVDA HVGKHIFENV IGPKGMLKNK TRILVTHSMS YLPQVDVIIV
     MSGGKISEMG SYQELLARDG AFAEFLRTYA STEQEQDAEE NGVTGVSGPG KEAKQMENGM
     LVTDSAGKQL QRQLSSSSSY SGDISRHHNS TAELQKAEAK KEETWKLMEA DKAQTGQVKL
     SVYWDYMKAI GLFISFLSIF LFMCNHVSAL ASNYWLSLWT DDPIVNGTQE HTKVRLSVYG
     ALGISQGIAV FGYSMAVSIG GILASRCLHV DLLHSILRSP MSFFERTPSG NLVNRFSKEL
     DTVDSMIPEV IKMFMGSLFN VIGACIVILL ATPIAAIIIP PLGLIYFFVQ RFYVASSRQL
     KRLESVSRSP VYSHFNETLL GVSVIRAFEE QERFIHQSDL KVDENQKAYY PSIVANRWLA
     VRLECVGNCI VLFAALFAVI SRHSLSAGLV GLSVSYSLQV TTYLNWLVRM SSEMETNIVA
     VERLKEYSET EKEAPWQIQE TAPPSSWPQV GRVEFRNYCL RYREDLDFVL RHINVTINGG
     EKVGIVGRTG AGKSSLTLGL FRINESAEGE IIIDGINIAK IGLHDLRFKI TIIPQDPVLF
     SGSLRMNLDP FSQYSDEEVW TSLELAHLKD FVSALPDKLD HECAEGGENL SVGQRQLVCL
     ARALLRKTKI LVLDEATAAV DLETDDLIQS TIRTQFEDCT VLTIAHRLNT IMDYTRVIVL
     DKGEIQEYGA PSDLLQQRGL FYSMAKDAGL V
//
